Literature DB >> 33994067

Acute pancreatitis-induced islet dysfunction in ferrets.

Yaling Yi1, Xingshen Sun1, Bo Liang1, Nan He1, Katherine N Gibson-Corley2, Andrew W Norris3, John F Engelhardt4, Aliye Uc5.   

Abstract

BACKGROUND: /
Objectives: The pathogenesis of hyperglycemia during acute pancreatitis (AP) remains unknown due to inaccessibility of human tissues and lack of animal models. We aimed to develop an animal model to study the mechanisms of hyperglycemia and impaired glucose tolerance in AP.
METHODS: We injected ferrets with intraperitoneal cerulein (50 μg/kg, 9 hourly injections) or saline. Blood samples were collected for glucose (0, 4, 8, 12, 24h); TNF-α, IL-6 (6h); amylase, lipase, insulin, glucagon, pancreatic polypeptide (PP), glucagon-like peptide-1 (GLP-1), and gastric inhibitory polypeptide (GIP) (24h). Animals underwent oral glucose tolerance test (OGTT), mixed meal tolerance test (MMTT) at 24h or 3 months, followed by harvesting pancreas for histopathology and immunostaining.
RESULTS: Cerulein-injected ferrets exhibited mild pancreatic edema, neutrophil infiltration, and elevations in serum amylase, lipase, TNF-α, IL-6, consistent with AP. Plasma glucose was significantly higher in ferrets with AP at all time points. Plasma glucagon, GLP-1 and PP were significantly higher in cerulein-injected animals, while plasma insulin was significantly lower compared to controls. OGTT and MMTT showed abnormal glycemic responses with higher area under the curve. The hypoglycemic response to insulin injection was completely lost, suggestive of insulin resistance. OGTT showed low plasma insulin; MMTT confirmed low insulin and GIP; abnormal OGTT and MMTT responses returned to normal 3 months after cerulein injection.
CONCLUSIONS: Acute cerulein injection causes mild acute pancreatitis in ferrets and hyperglycemia related to transient islet cell dysfunction and insulin resistance. The ferret cerulein model may contribute to the understanding of hyperglycemia in acute pancreatitis.
Copyright © 2021 IAP and EPC. Published by Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Glucagon; Glucose intolerance; Incretins; Insulin; Pancreatitis

Mesh:

Substances:

Year:  2021        PMID: 33994067      PMCID: PMC8355067          DOI: 10.1016/j.pan.2021.04.008

Source DB:  PubMed          Journal:  Pancreatology        ISSN: 1424-3903            Impact factor:   3.977


  55 in total

1.  Incidence, Admission Rates, and Predictors, and Economic Burden of Adult Emergency Visits for Acute Pancreatitis: Data From the National Emergency Department Sample, 2006 to 2012.

Authors:  Sushil K Garg; Shashank Sarvepalli; James P Campbell; Itegbemie Obaitan; Dupinder Singh; Fateh Bazerbachi; Rajeshwar Singh; Madhusudhan R Sanaka
Journal:  J Clin Gastroenterol       Date:  2019-03       Impact factor: 3.062

Review 2.  Type 3c (pancreatogenic) diabetes mellitus secondary to chronic pancreatitis and pancreatic cancer.

Authors:  Phil A Hart; Melena D Bellin; Dana K Andersen; David Bradley; Zobeida Cruz-Monserrate; Christopher E Forsmark; Mark O Goodarzi; Aida Habtezion; Murray Korc; Yogish C Kudva; Stephen J Pandol; Dhiraj Yadav; Suresh T Chari
Journal:  Lancet Gastroenterol Hepatol       Date:  2016-10-12

3.  Gastrointestinal pathology in juvenile and adult CFTR-knockout ferrets.

Authors:  Xingshen Sun; Alicia K Olivier; Yaling Yi; Christopher E Pope; Hillary S Hayden; Bo Liang; Hongshu Sui; Weihong Zhou; Kyle R Hager; Yulong Zhang; Xiaoming Liu; Ziying Yan; John T Fisher; Nicholas W Keiser; Yi Song; Scott R Tyler; J Adam Goeken; Joann M Kinyon; Matthew C Radey; Danielle Fligg; Xiaoyan Wang; Weiliang Xie; Thomas J Lynch; Paul M Kaminsky; Mitchell J Brittnacher; Samuel I Miller; Kalpaj Parekh; David K Meyerholz; Lucas R Hoffman; Timothy Frana; Zoe A Stewart; John F Engelhardt
Journal:  Am J Pathol       Date:  2014-03-15       Impact factor: 4.307

Review 4.  Animal Models: Challenges and Opportunities to Determine Optimal Experimental Models of Pancreatitis and Pancreatic Cancer.

Authors:  Jami L Saloman; Kathryn M Albers; Zobeida Cruz-Monserrate; Brian M Davis; Mouad Edderkaoui; Guido Eibl; Ariel Y Epouhe; Jeremy Y Gedeon; Fred S Gorelick; Paul J Grippo; Guy E Groblewski; Sohail Z Husain; Keane K Y Lai; Stephen J Pandol; Aliye Uc; Li Wen; David C Whitcomb
Journal:  Pancreas       Date:  2019-07       Impact factor: 3.327

5.  Disease phenotype of a ferret CFTR-knockout model of cystic fibrosis.

Authors:  Xingshen Sun; Hongshu Sui; John T Fisher; Ziying Yan; Xiaoming Liu; Hyung-Ju Cho; Nam Soo Joo; Yulong Zhang; Weihong Zhou; Yaling Yi; Joann M Kinyon; Diana C Lei-Butters; Michelle A Griffin; Paul Naumann; Meihui Luo; Jill Ascher; Kai Wang; Timothy Frana; Jeffrey J Wine; David K Meyerholz; John F Engelhardt
Journal:  J Clin Invest       Date:  2010-08-25       Impact factor: 14.808

Review 6.  Pancreatic islet plasticity: interspecies comparison of islet architecture and composition.

Authors:  Donald J Steiner; Abraham Kim; Kevin Miller; Manami Hara
Journal:  Islets       Date:  2010 May-Jun       Impact factor: 2.694

7.  Severity of insulin resistance in critically ill medical patients.

Authors:  Alexandra Zauner; Petra Nimmerrichter; Christian Anderwald; Martin Bischof; Mark Schiefermeier; Klaus Ratheiser; Bruno Schneeweiss; Christian Zauner
Journal:  Metabolism       Date:  2007-01       Impact factor: 8.694

8.  Impact of chronic stress hormone infusion on hepatic carbohydrate metabolism in the conscious dog.

Authors:  O P McGuinness; T Fugiwara; S Murrell; D Bracy; D Neal; D O'Connor; A D Cherrington
Journal:  Am J Physiol       Date:  1993-08

Review 9.  Principles for valid histopathologic scoring in research.

Authors:  K N Gibson-Corley; A K Olivier; D K Meyerholz
Journal:  Vet Pathol       Date:  2013-04-04       Impact factor: 2.221

10.  Beta-cell reserve capacity in chronic pancreatitis.

Authors:  S Domschke; K P Stock; J Pichl; M U Schneider; W Domschke
Journal:  Hepatogastroenterology       Date:  1985-02
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.